Tesamorelin stands out with a robust clinical corpus including pivotal phase 3 trials on over 800 patients (HIV lipodystrophy indication), with 52-week data documenting a significant reduction in visceral fat (visceral adipose tissue, VAT) and improved lipid parameters
J Mol Med 76: 581588
Semin Oncol 1998
Calculations of key parameters of the mitochondrial function were performed, consisting of basal respiration (BR, OCR initial OCR rot/AA ), ATP production (ATP, OCR initial - OCR oligo ), proton leak (PL, OCR oligo OCR rot/AA ), maximal respiration (MR, OCR FCCP OCR rot/AA ), spare respiratory capacity (SRC, OCR FCCP - OCR initial ), spare respiratory capacity [%] (SRCP, MR/BR*100), non-mitochondrial respiration rate (NMRR, OCR rot/AA ), and coupling efficiency [%] (CE, ATP/BR*100)
The Statistics: Who Is Using These Medications 1 in 8 Americans reported using a GLP-1 medication as of 2025 (Gallup National Health and Well-Being Index, 2025) 12.4% of Americans reported GLP-1 use in late 2025 more than double the 5.8% reported in February 2024 40 million+ GLP-1 prescriptions were written in the United States in 2024 alone Approximately 63% of patients who began Wegovy or Zepbound in early 2024 remained on therapy one year later, up from 40% among the 2023 cohort
Pillai, S